Compare PTCT & ABCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | ABCB |
|---|---|---|
| Founded | 1998 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.1B |
| IPO Year | 2006 | 2010 |
| Metric | PTCT | ABCB |
|---|---|---|
| Price | $69.04 | $84.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 7 |
| Target Price | $80.65 | ★ $85.71 |
| AVG Volume (30 Days) | ★ 733.3K | 506.1K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ 264.48 | 15.61 |
| EPS | ★ 7.78 | 6.00 |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $14.70 |
| Revenue Next Year | $17.70 | $5.97 |
| P/E Ratio | ★ $8.75 | $14.14 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $35.95 | $56.42 |
| 52 Week High | $87.50 | $87.98 |
| Indicator | PTCT | ABCB |
|---|---|---|
| Relative Strength Index (RSI) | 48.31 | 65.47 |
| Support Level | $64.00 | $73.11 |
| Resistance Level | $69.23 | $87.98 |
| Average True Range (ATR) | 2.38 | 1.69 |
| MACD | -0.33 | 0.19 |
| Stochastic Oscillator | 25.12 | 68.59 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. The company intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.